Alexander Gutfraind

MedicinePhysics and AstronomyEngineeringSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Effectiveness of isolation policies in schools: evidence from a mathematical model of influenza and COVID-19”.

Effectiveness of isolation policies in schools: evidence from a mathematical model of influenza and COVID-19

PeerJ(2021)10.7717/peerj.11211

N/A

0DataRank · unranked

9 citations

Alexander Gutfraind, Adam A. C. Burns

Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago

PLoS ONE(2022)10.1371/journal.pone.0264983

N/A

0DataRank · unranked

19 citations

Alexander Gutfraind, Nicholson Collier, Desarae Echevarria, Scott J. Cotler, Marian Major +4 more

On strategies for risk management and decision making under uncertainty shared across multiple fields

arXiv (Cornell University)(2023)10.48550/arxiv.2309.03133

N/A

0DataRank · unranked

1 citations

Alexander Gutfraind

Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs

SSRN Electronic Journal(2023)10.2139/ssrn.4370294

N/A

0DataRank · unranked

0 citations

Eric Tatara, Mary Ellen Mackesy‐Amiti, Kimberly Page, Jonathan Ozik, Basmatee Boodrum +3 more

Reducing Sample Size While Improving Equity in Vaccine Clinical Trials: A Machine Learning-Based Recruitment Methodology with Application to Improving Trials of Hepatitis C Virus Vaccines in People Who Inject Drugs

Healthcare(2024)10.3390/healthcare12060644

N/A

0DataRank · unranked

5 citations

Eric Tatara, Mary Ellen Mackesy‐Amiti, Kimberly Page, Jonathan Ozik, Basmattee Boodram +3 more

Modeling of randomized hepatitis C vaccine trials: Bridging the gap between controlled human infection models and real-word testing

PNAS Nexus(2024)10.1093/pnasnexus/pgae564

N/A

0DataRank · unranked

3 citations

Alexander Gutfraind, Eric Tatara, Nicholson Collier, Scott J. Cotler, Kimberly Page +5 more

Modern approaches to predicting vaccine hesitancy: A scoping review

medRxiv(2025)10.1101/2025.01.29.25321367

N/A

0DataRank · unranked

0 citations

Sami Alahmadi, Rosie Hanneke, Alexander Gutfraind, Keshav Gandhi

Modern approaches to predicting vaccine hesitancy: A scoping review

Vaccine X(2025)10.1016/j.jvacx.2025.100655

N/A

0DataRank · unranked

0 citations

Sami Alahmadi, Rosie Hanneke, Alexander Gutfraind, Keshav Gandhi

Challenges in coverage of future hepatitis C vaccines: Review and potential solutions

Vaccine(2025)10.1016/j.vaccine.2025.127256

N/A

0DataRank · unranked

0 citations

Yash Vijay, Kimberly Page, Harel Dahari, Alexander Gutfraind, Keshav Gandhi